Cargando…
BET inhibitor suppresses migration of human hepatocellular carcinoma by inhibiting SMARCA4
Hepatocellular carcinoma (HCC) is one of the most prevalent and poorly responsive cancers worldwide. Bromodomain and extraterminal (BET) inhibitors, such as JQ1 and OTX-015, inhibit BET protein binding to acetylated residues in histones. However, the physiological mechanisms and regulatory processes...
Autores principales: | Choi, Hae In, An, Ga Yeong, Baek, Mina, Yoo, Eunyoung, Chai, Jin Choul, Lee, Young Seek, Jung, Kyoung Hwa, Chai, Young Gyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175750/ https://www.ncbi.nlm.nih.gov/pubmed/34083693 http://dx.doi.org/10.1038/s41598-021-91284-2 |
Ejemplares similares
-
The BET inhibitor attenuates the inflammatory response and cell migration in human microglial HMC3 cell line
por: Baek, Mina, et al.
Publicado: (2021) -
Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells
por: Baek, Mina, et al.
Publicado: (2022) -
The bromodomain inhibitor JQ1 up-regulates the long non-coding RNA MALAT1 in cultured human hepatic carcinoma cells
por: Choi, Hae In, et al.
Publicado: (2022) -
Targeting of non-coding RNAs encoded by novel MYC enhancers inhibits the proliferation of human hepatic carcinoma cells in vitro
por: Choi, Hae In, et al.
Publicado: (2022) -
Analysis of differentially expressed long non-coding RNAs in LPS-induced human HMC3 microglial cells
por: Baek, Mina, et al.
Publicado: (2022)